MEDIA ADVISORY: Computational Medicine Day explores supercomputing in medicine
May 12, 2014
EVENT: The university’s first Computational Medicine Day.
WHEN: May 13, 2014.
WHERE: The O’Donnell Building for Applied Computational Engineering and Sciences, Avaya Auditorium, 201 E. 24th St., Austin, Texas 78712.
BACKGROUND: The Institute for Computational Engineering and Sciences (ICES) Committee on Computational Medicine (Professor Michael Sacks, chair) will host the invitational Computational Medicine Day in collaboration with the Dell Medical School to explore the benefits of supercomputing technologies when applied to medicine. Computational medicine is an emerging field that uses supercomputers for computer modeling, simulation and data-enabling technologies to promote advances in medical diagnostics and therapies.
Many advantages exist when applying computer technology to simulate human physiology, such as providing physicians the ability to try “what if” scenarios to understand the effects of a therapy on a patient. The result is optimized and cost-effective medicine with reduced mortality, better re-operative rates and faster recovery times.
Success in computational medicine requires a strategic partnership between the computational and medical sciences. ICES possesses nationally renowned expertise in computational methods and technologies. With the advent of the Dell Medical School, the university now has the ability to co-develop and implement novel computational-based methods of diagnosis and treatment.
The conference will provide an overview of computational medicine; highlight ICES’ computational work, which includes cardiovascular research, cancer research and drug design and delivery methods; and provide a forum for discussion and future collaboration.
State Sen. Kirk Watson, UT Vice President of Research Juan Sanchez, ICES Director Tinsley Oden, Dell Medical School Dean Clay Johnston, and ICES professors conducting computational medical research will be among the speakers. Attendees will include representatives from the Texas Heart Institute, St. David’s Medical, Seton Hospital, St. Jude Medical, Medtronic and Capsenta.